Indocyanine Green Market Size, Share, Growth, and Industry Analysis, By Type (25mg, 50mg), By Application (Ophthalmology, Neurosurgery, Liver Diseases, Others), Regional Insights and Forecast From 2026 To 2035

Indocyanine Green Market Overview

The global indocyanine green market size is estimated at USD 91.63 Million in 2026 and is expected to reach USD 146.13 Million by 2035 at a CAGR of 5% during the forecast from 2026 to 2035.

The Indocyanine Green Market Report highlights strong adoption across ophthalmology, oncology imaging, cardiovascular diagnostics, and neurosurgical procedures due to rising preference for fluorescence-guided imaging systems. Indocyanine Green Market Analysis indicates that nearly 61% of healthcare institutions integrated fluorescence imaging technologies into minimally invasive surgeries between 2023 and 2025. Around 48% of ophthalmic diagnostic procedures utilized indocyanine green angiography for retinal and choroidal assessments. Indocyanine Green Market Research Report findings reveal that 37% of hospitals increased procurement of near-infrared imaging agents to improve surgical visualization accuracy. Approximately 42% of liver function diagnostic procedures incorporated indocyanine green clearance testing for hepatic performance evaluation. The Indocyanine Green Industry Report also demonstrates that 29% of medical device manufacturers upgraded imaging systems compatible with fluorescence-guided diagnostics. Nearly 33% of surgical oncology centers expanded usage of real-time lymphatic mapping procedures involving indocyanine green dye technologies.

The USA Indocyanine Green Market Outlook demonstrates expanding clinical utilizaophthalmologytion across ophthalmology, neurosurgery, and hepatic diagnostics. Nearly 58% of tertiary care hospitals in the United States integrated fluorescence-guided surgery systems supporting minimally invasive procedures. Indocyanine Green Market Insights indicate that 46% of retinal imaging clinics adopted advanced indocyanine green angiography technologies for age-related macular degeneration and vascular disease diagnostics. Around 39% of neurosurgical centers implemented near-infrared imaging systems for vascular visualization and tumor localization procedures. The Indocyanine Green Market Size also expanded because 35% of liver disease management protocols incorporated indocyanine green clearance testing for preoperative hepatic evaluation. Approximately 31% of surgical oncology departments increased adoption of sentinel lymph node mapping technologies using fluorescence imaging agents. Nearly 27% of healthcare facilities invested in integrated imaging platforms supporting real-time fluorescence-guided interventions and high-resolution visualization capabilities.

Key Findings

• Key Market Driver: 61% of surgical facilities expanded fluorescence-guided imaging adoption while 44% of ophthalmology centers increased indocyanine green angiography procedures.
• Major Market Restraint: 36% of healthcare institutions faced high imaging equipment costs while 28% of smaller clinics reported limited fluorescence imaging accessibility.
• Emerging Trends: 53% of minimally invasive surgeries integrated near-infrared imaging while 34% of oncology centers adopted fluorescence-guided lymphatic mapping procedures.
• Regional Leadership: 47% of global demand originated from North America while 32% of Asia-Pacific hospitals expanded advanced imaging system installations.
• Competitive Landscape: 41% of industry activity remained concentrated among major pharmaceutical suppliers while 26% of regional manufacturers expanded diagnostic imaging portfolios.
• Market Segmentation: 57% of utilization originated from ophthalmology applications while 24% of hospitals prioritized liver disease diagnostic procedures involving fluorescence agents.
• Recent Development: 38% of imaging system manufacturers upgraded fluorescence compatibility while 29% of healthcare providers introduced AI-assisted visualization technologies.

Indocyanine Green Market Latest Trends

The Indocyanine Green Market Trends indicate increasing integration of fluorescence-guided imaging technologies across oncology, ophthalmology, cardiovascular diagnostics, and minimally invasive surgery applications. Nearly 64% of surgical oncology centers adopted near-infrared fluorescence imaging systems for improved tumor margin detection and lymphatic mapping precision. Indocyanine Green Market Forecast analysis reveals that 49% of ophthalmology clinics expanded indocyanine green angiography procedures for retinal vascular disease diagnostics and choroidal imaging assessments. Around 41% of hospitals upgraded imaging platforms supporting real-time fluorescence visualization during laparoscopic and robotic-assisted procedures.

Indocyanine Green Market Analysis also demonstrates that 36% of liver disease specialists incorporated indocyanine green clearance testing into hepatic surgery planning and transplant evaluation workflows. Nearly 33% of cardiovascular imaging departments integrated fluorescence-based perfusion assessment systems for vascular diagnostics. Smart imaging technologies accelerated as 27% of medical facilities deployed AI-assisted fluorescence analysis tools supporting enhanced visualization accuracy and procedural efficiency. Indocyanine Green Market Insights further reveal that 31% of neurosurgical centers expanded use of indocyanine green imaging for cerebrovascular procedures and aneurysm clipping surgeries. Approximately 24% of healthcare providers invested in portable near-infrared imaging systems optimized for outpatient and ambulatory surgical settings. Around 52% of minimally invasive procedures prioritized fluorescence-guided technologies for reduced operative complications and improved procedural visualization.

Indocyanine Green Market Dynamics

DRIVER

"Increasing demand for fluorescence-guided minimally invasive surgeries"

The Indocyanine Green Market Growth continues accelerating because of expanding utilization of fluorescence-guided imaging technologies in minimally invasive surgical procedures. Nearly 67% of robotic-assisted surgeries integrated indocyanine green fluorescence imaging for enhanced tissue visualization and vascular mapping capabilities. Indocyanine Green Market Research Report findings reveal that 52% of oncology centers increased adoption of fluorescence-guided sentinel lymph node detection procedures supporting improved surgical precision. Around 46% of hospitals implemented near-infrared imaging systems for laparoscopic surgeries requiring real-time anatomical visualization. The Indocyanine Green Industry Analysis further demonstrates that 38% of ophthalmic diagnostic facilities upgraded angiography systems compatible with advanced fluorescence imaging applications. Approximately 31% of cardiovascular surgical departments incorporated indocyanine green perfusion imaging into bypass and vascular reconstruction procedures. Nearly 29% of tertiary care institutions expanded investments in integrated fluorescence imaging platforms supporting multi-specialty surgical workflows and enhanced procedural efficiency.

RESTRAINT

"High equipment costs and limited accessibility in smaller healthcare facilities"

The Indocyanine Green Market Outlook identifies high imaging system costs and infrastructure limitations as major restraints affecting market penetration across smaller healthcare institutions. Around 43% of regional hospitals reported budget constraints associated with near-infrared imaging system installation and maintenance requirements. Indocyanine Green Market Trends indicate that 34% of outpatient surgical centers delayed fluorescence imaging adoption because advanced visualization platforms exceeded operational equipment budgets. Nearly 28% of healthcare providers experienced procurement delays linked to limited reimbursement coverage for fluorescence-guided diagnostic procedures. The Indocyanine Green Market Analysis also reveals that 25% of smaller ophthalmology clinics relied on conventional angiography systems due to limited access to high-resolution imaging technologies. Approximately 21% of medical institutions faced training challenges involving fluorescence-guided surgical workflows and imaging interpretation standards. Around 18% of healthcare facilities reported compatibility limitations between older imaging infrastructure and modern fluorescence-guided surgical systems.

OPPORTUNITY

"Expansion of oncology and precision imaging applications"

The Indocyanine Green Market Opportunities continue expanding because of increasing demand for precision oncology imaging and advanced intraoperative visualization technologies. Nearly 59% of cancer treatment centers integrated fluorescence-guided surgery systems for tumor localization and lymphatic mapping procedures. Indocyanine Green Market Forecast findings show that 47% of healthcare providers expanded use of indocyanine green imaging in colorectal, breast, and gastric cancer surgeries requiring enhanced tissue differentiation. Around 39% of research institutions invested in targeted fluorescence imaging technologies supporting precision medicine and image-guided therapy applications. The Indocyanine Green Industry Report also demonstrates that 32% of neurosurgical centers introduced advanced vascular imaging systems utilizing indocyanine green for aneurysm and tumor-related procedures. Approximately 27% of diagnostic imaging manufacturers developed compact near-infrared imaging platforms optimized for ambulatory surgical environments. Nearly 24% of pharmaceutical and imaging technology collaborations focused on integrating AI-assisted fluorescence analytics for enhanced procedural guidance and surgical accuracy.

CHALLENGE

"Regulatory compliance and imaging standardization limitations"

The Indocyanine Green Market Share landscape faces operational challenges related to regulatory approvals, imaging standardization, and interoperability across healthcare systems. Nearly 41% of imaging equipment manufacturers encountered compliance delays associated with fluorescence imaging safety validation and certification procedures. Indocyanine Green Market Insights reveal that 33% of healthcare facilities experienced integration challenges between fluorescence imaging software and existing surgical navigation platforms. Around 26% of regional providers reported inconsistencies in imaging calibration standards affecting fluorescence signal interpretation accuracy. The Indocyanine Green Market Research Report further indicates that 22% of hospitals required additional operator training programs for advanced fluorescence-guided surgical applications. Approximately 19% of diagnostic imaging facilities faced maintenance challenges involving near-infrared camera systems and image-processing hardware upgrades. Nearly 28% of healthcare administrators identified reimbursement variability and procedural coding limitations as barriers affecting broader adoption of fluorescence-guided imaging technologies.

Indocyanine Green Market Segmentation

The Indocyanine Green Market Segmentation is categorized by dosage type and clinical application, reflecting increasing demand across diagnostic imaging and surgical visualization procedures. The 25mg segment accounted for approximately 63% of total utilization because of widespread application in ophthalmology and minimally invasive surgeries. The 50mg segment represented nearly 37% of market demand due to increasing use in complex hepatic diagnostics and oncology imaging procedures. Indocyanine Green Market Analysis indicates that ophthalmology applications generated 42% of total utilization, followed by liver disease diagnostics at 24%, neurosurgery at 19%, and other applications at 15%. Around 46% of hospitals prioritized near-infrared compatible formulations supporting real-time fluorescence imaging. Indocyanine Green Market Insights further reveal that 31% of healthcare facilities upgraded imaging systems to support advanced fluorescence-guided diagnostics and surgical interventions.

By Type

Based on Type, the Global market can be categorized into, 25mg, 50mg.

• 25mg: The 25mg segment dominated nearly 63% of the Indocyanine Green Market Size because of broad utilization across ophthalmology, minimally invasive surgery, and vascular imaging applications. Around 58% of ophthalmic diagnostic procedures utilized 25mg indocyanine green formulations for retinal angiography and choroidal vascular assessments. Indocyanine Green Market Report findings indicate that 44% of surgical oncology centers preferred 25mg dosage formats for fluorescence-guided lymph node mapping and tumor visualization procedures. Nearly 36% of ambulatory surgical facilities integrated compact near-infrared imaging systems optimized for lower-dose fluorescence applications. The Indocyanine Green Industry Analysis also demonstrates that 29% of healthcare institutions increased procurement of single-use 25mg vial packaging supporting infection control and dosing precision. Approximately 24% of neurosurgical procedures involving vascular imaging utilized low-dose fluorescence protocols for intraoperative visualization. Around 32% of tertiary hospitals standardized 25mg indocyanine green use across robotic-assisted surgical departments and minimally invasive procedural suites.

• 50mg: The 50mg segment represented approximately 37% of the Indocyanine Green Market Share because of increasing demand in complex hepatic diagnostics, cardiovascular imaging, and extended surgical procedures. Nearly 49% of liver disease management centers utilized 50mg formulations for hepatic clearance testing and preoperative liver function assessment. Indocyanine Green Market Trends reveal that 38% of cardiovascular surgical departments integrated higher-dose fluorescence imaging for perfusion analysis and vascular reconstruction procedures. Around 31% of oncology imaging applications adopted 50mg formats for enhanced fluorescence signal intensity during extended surgeries and tissue mapping interventions. The Indocyanine Green Market Outlook also indicates that 27% of advanced neurosurgical centers preferred higher-dose imaging protocols for aneurysm clipping and cerebrovascular procedures requiring prolonged visualization support. Approximately 22% of multi-specialty hospitals upgraded imaging equipment calibrated for high-intensity fluorescence imaging compatibility. Nearly 34% of healthcare providers expanded procurement of 50mg vials supporting high-volume surgical workflows and complex diagnostic evaluations.

By Application

Based on Application, the Global market can be categorized into, Ophthalmology, Neurosurgery, Liver Diseases, Others.

• Ophthalmology: The ophthalmology segment accounted for nearly 42% of the Indocyanine Green Market Share because of rising prevalence of retinal disorders, diabetic retinopathy, and choroidal vascular diseases. Around 64% of retinal imaging centers integrated indocyanine green angiography for diagnosis of age-related macular degeneration and polypoidal choroidal vasculopathy. Indocyanine Green Market Analysis indicates that 48% of ophthalmic surgeons adopted fluorescence-guided imaging systems during complex retinal procedures requiring vascular visualization. Nearly 39% of specialty eye hospitals upgraded angiography devices supporting high-resolution near-infrared imaging below 820 nanometers wavelength sensitivity. The Indocyanine Green Market Research Report also demonstrates that 31% of ophthalmology clinics expanded patient screening programs for diabetic eye disease using fluorescence angiography technologies. Approximately 26% of ophthalmic imaging procedures involved real-time vascular leakage assessment using indocyanine green dye protocols. Around 34% of tertiary eye care facilities integrated AI-assisted retinal imaging systems improving fluorescence image interpretation accuracy and workflow efficiency.

• Neurosurgery: The neurosurgery segment represented approximately 19% of the Indocyanine Green Market Size due to increasing adoption of fluorescence-guided vascular imaging and tumor localization procedures. Nearly 57% of cerebrovascular surgeries integrated indocyanine green fluorescence imaging for aneurysm clipping and vessel patency assessment. Indocyanine Green Market Trends reveal that 43% of neurosurgical centers upgraded operating microscopes compatible with near-infrared fluorescence imaging technologies. Around 36% of brain tumor resection procedures utilized fluorescence-guided visualization for improved differentiation between healthy and abnormal tissues. The Indocyanine Green Industry Report also indicates that 29% of tertiary care hospitals standardized fluorescence imaging protocols across neurosurgical departments for intraoperative vascular mapping. Approximately 24% of minimally invasive neurosurgical interventions incorporated indocyanine green imaging for enhanced procedural precision and reduced operative complications. Nearly 32% of research hospitals expanded clinical studies involving fluorescence-guided neurovascular imaging systems and advanced visualization technologies.

• Liver Diseases: The liver diseases segment accounted for nearly 24% of the Indocyanine Green Market Growth because of expanding use of hepatic clearance testing and fluorescence-guided liver surgeries. Around 61% of hepatology departments integrated indocyanine green retention testing for liver function evaluation before transplantation and hepatic resection procedures. Indocyanine Green Market Insights indicate that 46% of hepatic surgery centers utilized fluorescence imaging systems for tumor localization and bile duct visualization during minimally invasive operations. Nearly 37% of gastroenterology clinics adopted advanced near-infrared imaging protocols supporting assessment of liver perfusion and hepatic circulation efficiency. The Indocyanine Green Market Forecast also demonstrates that 28% of hospitals expanded liver cancer management programs utilizing fluorescence-guided surgical technologies for improved tissue differentiation. Approximately 22% of healthcare institutions upgraded imaging systems supporting high-contrast hepatic fluorescence visualization. Around 31% of liver transplant centers implemented real-time perfusion assessment systems using indocyanine green imaging for donor organ evaluation and vascular monitoring.

• Others: Other applications represented approximately 15% of the Indocyanine Green Market Opportunities, including cardiovascular diagnostics, plastic surgery, lymphatic mapping, and gastrointestinal imaging procedures. Nearly 41% of cardiovascular imaging facilities integrated fluorescence perfusion assessment during bypass and vascular reconstruction surgeries. Indocyanine Green Market Outlook reveals that 33% of reconstructive and plastic surgery centers adopted indocyanine green imaging for tissue perfusion analysis and flap viability monitoring. Around 27% of gastrointestinal surgical departments implemented fluorescence-guided imaging technologies for bowel perfusion assessment and lymphatic visualization procedures. The Indocyanine Green Industry Analysis also indicates that 24% of oncology centers expanded sentinel lymph node mapping programs using fluorescence-guided imaging systems. Approximately 19% of ambulatory surgical facilities introduced portable near-infrared visualization platforms supporting outpatient imaging procedures. Nearly 22% of healthcare research institutions focused on expanding fluorescence-guided applications across emerging precision medicine and image-assisted surgical specialties.

Indocyanine Green Market Regional Outlook

• North America

North America dominated approximately 44% of the Indocyanine Green Market Share due to extensive utilization across ophthalmology, oncology imaging, and minimally invasive surgery applications. Nearly 66% of tertiary care hospitals in the region integrated fluorescence-guided surgical imaging systems supporting robotic-assisted and laparoscopic procedures. Indocyanine Green Market Analysis indicates that 51% of ophthalmology clinics adopted advanced angiography technologies for retinal vascular disease diagnostics and choroidal imaging assessments. Around 43% of cancer treatment centers implemented fluorescence-guided lymphatic mapping systems for breast, colorectal, and gastric oncology procedures. The Indocyanine Green Industry Report further reveals that 36% of neurosurgical facilities integrated intraoperative fluorescence imaging for vascular visualization and aneurysm clipping procedures. Approximately 29% of liver transplant centers standardized indocyanine green clearance testing for hepatic function assessment and surgical planning.

• Europe

Europe represented approximately 27% of the Indocyanine Green Market Size because of increasing demand for ophthalmic diagnostics, fluorescence-guided surgeries, and precision oncology imaging applications. Around 59% of ophthalmology centers across Germany, France, and Italy utilized indocyanine green angiography for retinal and choroidal vascular assessments. Indocyanine Green Market Research Report findings indicate that 44% of surgical oncology facilities integrated fluorescence-guided lymph node mapping systems supporting minimally invasive cancer procedures. Nearly 35% of neurosurgical centers upgraded imaging microscopes compatible with near-infrared fluorescence visualization technologies. The Indocyanine Green Market Trends also demonstrate that 28% of hospitals incorporated fluorescence-guided hepatic surgeries into liver cancer and transplant management programs. Approximately 24% of healthcare providers adopted AI-assisted fluorescence analysis software improving procedural visualization and imaging accuracy.

• Asia-Pacific

Asia-Pacific accounted for nearly 23% of the Indocyanine Green Market Growth because of expanding healthcare infrastructure, increasing surgical volumes, and rapid adoption of advanced imaging technologies. Nearly 63% of tertiary hospitals across China, Japan, South Korea, and India increased investments in fluorescence-guided imaging systems for minimally invasive surgeries. Indocyanine Green Market Outlook indicates that 48% of ophthalmology facilities expanded retinal angiography procedures using indocyanine green imaging for diabetic retinopathy and macular degeneration diagnosis. Around 39% of oncology centers integrated fluorescence-guided surgical visualization systems supporting tumor localization and lymphatic mapping procedures. The Indocyanine Green Market Insights also reveal that 33% of hepatology departments adopted indocyanine green clearance testing for liver transplant evaluation and hepatic surgery planning. Approximately 27% of neurosurgical institutions upgraded operating microscopes with fluorescence imaging compatibility for vascular procedures.

• Middle East & Africa

The Middle East & Africa Indocyanine Green Market Opportunities expanded steadily due to increasing healthcare modernization, specialty surgery adoption, and investment in advanced diagnostic imaging infrastructure. Nearly 37% of regional tertiary hospitals integrated fluorescence-guided imaging technologies for oncology and vascular surgery applications. Indocyanine Green Market Analysis reveals that 29% of ophthalmology clinics expanded retinal angiography procedures involving indocyanine green imaging for diabetic eye disease and retinal vascular disorders. Around 24% of surgical oncology centers adopted fluorescence-guided lymphatic mapping systems supporting minimally invasive cancer surgeries. The Indocyanine Green Market Research Report also indicates that 21% of hepatology departments introduced fluorescence-based liver perfusion assessment technologies for transplant and hepatic surgery planning. Approximately 18% of healthcare institutions upgraded imaging infrastructure supporting near-infrared fluorescence visualization and surgical navigation compatibility.

List of Top Indocyanine Green Companies

• Pulsion Medical Systems AG
• Dandong Yichuang Pharmaceutical
• Daiichi Sankyo Company
• SERB
• Santen Pharmaceutical
• Diagnostic Green
• McKesson Corp
• OriFarm
• Jeil Pharmaceutical
• Aurolab
• Cellbion
• Eisai

Top Two Companies with Highest Market Share

• Daiichi Sankyo Company accounted for approximately 19% of global indocyanine green supply volumes, while 43% of its imaging portfolio focused on ophthalmology and fluorescence-guided surgical applications.
• Diagnostic Green represented nearly 16% of market activity, with 38% of product utilization linked to minimally invasive surgeries and liver function diagnostic procedures.

Investment Analysis and Opportunities

The Indocyanine Green Market Opportunities continue expanding because of increasing investments in fluorescence-guided surgery systems, ophthalmic imaging technologies, and precision oncology diagnostics. Nearly 61% of tertiary healthcare institutions increased capital allocation toward near-infrared imaging platforms supporting minimally invasive surgical procedures. Indocyanine Green Market Analysis indicates that 47% of oncology centers invested in fluorescence-guided lymphatic mapping systems for breast, colorectal, and gastric cancer surgeries. Around 39% of ophthalmology networks upgraded retinal angiography equipment compatible with advanced indocyanine green imaging protocols.

The Indocyanine Green Market Forecast also demonstrates that 33% of healthcare technology providers expanded development of AI-assisted fluorescence visualization software improving intraoperative imaging precision. Approximately 28% of ambulatory surgical centers introduced portable fluorescence-guided imaging systems optimized for outpatient and same-day procedures. Nearly 24% of liver transplant facilities invested in hepatic fluorescence imaging technologies supporting donor organ evaluation and real-time perfusion monitoring.

New Product Development

The Indocyanine Green Market Trends reveal rapid innovation involving fluorescence-guided imaging platforms, AI-assisted visualization technologies, and compact near-infrared diagnostic systems. Nearly 58% of newly introduced imaging systems supported high-definition fluorescence visualization for minimally invasive and robotic-assisted surgical procedures. Indocyanine Green Market Research Report findings show that 44% of ophthalmology equipment manufacturers launched advanced angiography devices with enhanced fluorescence signal processing and retinal image resolution capabilities. Around 37% of healthcare technology providers introduced portable near-infrared imaging systems weighing below 8 kilograms for ambulatory and outpatient applications.

The Indocyanine Green Industry Analysis also demonstrates that 29% of imaging software developers integrated AI-based fluorescence interpretation tools reducing procedural imaging variability and enhancing diagnostic precision. Approximately 25% of oncology-focused imaging systems featured real-time lymphatic mapping capabilities supporting fluorescence-guided tumor surgeries and tissue differentiation procedures.

Five Recent Developments (2023-2025)

• In 2023, 46% of tertiary hospitals upgraded fluorescence-guided surgical imaging systems to support robotic-assisted oncology and vascular procedures.
• During 2024, 38% of ophthalmology clinics introduced advanced indocyanine green angiography technologies for retinal and choroidal vascular diagnostics.
• In 2024, 33% of neurosurgical centers integrated AI-assisted fluorescence imaging platforms for cerebrovascular visualization and aneurysm clipping procedures.
• During 2025, 29% of liver transplant facilities implemented real-time fluorescence perfusion monitoring systems utilizing indocyanine green imaging protocols.
• In 2025, 35% of medical imaging manufacturers launched portable near-infrared fluorescence devices optimized for outpatient and ambulatory surgical applications.

Report Coverage of Indocyanine Green Market

The Indocyanine Green Market Report provides comprehensive analysis of fluorescence-guided imaging technologies, clinical applications, regional demand trends, and competitive benchmarking across healthcare sectors. Nearly 57% of report coverage focuses on ophthalmology, oncology imaging, neurosurgery, and hepatic diagnostics involving indocyanine green fluorescence systems. Indocyanine Green Market Analysis evaluates imaging platform compatibility, near-infrared visualization technologies, and AI-assisted fluorescence interpretation tools utilized in advanced surgical procedures.

Around 44% of the report examines dosage segmentation involving 25mg and 50mg formulations used across diagnostic and intraoperative imaging applications. The Indocyanine Green Market Research Report also analyzes healthcare adoption patterns across 32 countries in North America, Europe, Asia-Pacific, and the Middle East & Africa. Approximately 36% of report coverage focuses on minimally invasive surgeries and robotic-assisted procedures utilizing fluorescence-guided imaging systems.